Catalog No.
EVV19905
Expression system
Mammalian Cells
Species
Dengue virus type 4
Protein length
Arg281-Thr724
Predicted molecular weight
51.40 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
AGE13481.1
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution.A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Genome polyprotein, Envelope protein E
Antiviral in vitro activity of a novel dichlorinated tyrosine methyl ester derivative against the infection of two flaviviruses of public health concern, dengue and zika virus., PMID:40450991
Development of New Live-Attenuated Vaccine Candidates Lacking Antibody-Dependent Enhancement (ADE) Against Dengue., PMID:40432141
miRNome analysis reveals mir-155-5p as a protective factor to dengue infection in a resistant Thai cohort., PMID:39976655
RT-RPA Assisted CRISPR/Cas12a Based One-Pot Rapid and Visual Detection of the Pan-Dengue Virus., PMID:39949262
Genetic diversity of dengue virus circulating in the Philippines (2014-2019) and comparison with dengue vaccine strains., PMID:39700304
Efficacy and safety of Butantan-DV in participants aged 2-59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil., PMID:39116904
A 2D-proteomic analysis identifies proteins differentially regulated by two different dengue virus serotypes., PMID:38594317
E-Protein Protonation Titration-Induced Single-Particle Chemical Force Spectroscopy for Microscopic Understanding and pI Estimation of Infectious DENV., PMID:38512319
Characterization of Dengue Virus 4 Cases in Paraguay, 2019-2020., PMID:38399957
Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults., PMID:38294972
Serotype-associated immune response and network immunoclusters in children and adults during acute Dengue virus infection., PMID:37542834
Epitope prediction and designing of receptor inhibitor of Dengue Envelope Protein: An in silico approach., PMID:37417165
Experimental Dengue Virus Type 4 Infection Increases the Expression of MicroRNAs-15/16, Triggering a Caspase-Induced Apoptosis Pathway., PMID:37367040
Isolation and Genetic Evolution of Dengue Virus from the 2019 Outbreak in Xishuangbanna, Yunnan Province, China., PMID:37184906
Primary infection of BALB/c mice with a dengue virus type 4 strain leads to kidney injury., PMID:37162062
Evolutionary dynamics of dengue virus in India., PMID:37011104
Development of novel antiviral peptides against dengue serotypes 1-4., PMID:36739680
The dengue virus 4 component of NIAID's tetravalent TV003 vaccine drives its innate immune signature., PMID:36734144
Genetic diversity and spatiotemporal dynamics of DENV-1 and DENV-2 infections during the 2012-2013 outbreak in Mexico., PMID:35779336
Molecular Characterization and Identification of Potential Inhibitors for 'E' Protein of Dengue Virus., PMID:35632682
Mathematical models for dengue fever epidemiology: A 10-year systematic review., PMID:35219611
Virus-like particles with FLAG-tagged envelope protein as a tetravalent dengue vaccine candidate., PMID:34475493
Co-Circulation of All Four Dengue Viruses and Zika Virus in Guerrero, Mexico, 2019., PMID:33944623
Renal Injury in DENV-4 Fatal Cases: Viremia, Immune Response and Cytokine Profile., PMID:31703246
Spatio-temporal distribution analysis of circulating genotypes of dengue virus type 1 in western and southern states of India by a one-step real-time RT-PCR assay., PMID:31376506
Phylogenetic analysis of partial pre-membrane and envelope sequences of dengue viruses circulating in India., PMID:31002930
A Stillborn Multiple Organs' Investigation from a Maternal DENV-4 Infection: Histopathological and Inflammatory Mediators Characterization., PMID:30986974
Electroporation-Mediated Immunization of a Candidate DNA Vaccine Expressing Dengue Virus Serotype 4 prM-E Antigen Confers Long-Term Protection in Mice., PMID:30790202
Development of a Standardized Sanger-Based Method for Partial Sequencing and Genotyping of Dengue Viruses., PMID:30760533
In vitro analysis of synthetic peptides in blocking the entry of dengue virus., PMID:30508603
Emergence of dengue virus type 1 and type 3 as dominant serotypes during 2017 in Pune and Nashik regions of Maharashtra, Western India., PMID:30366083
Improvement of the Dengue Virus (DENV) Nonhuman Primate Model via a Reverse Translational Approach Based on Dengue Vaccine Clinical Efficacy Data against DENV-2 and -4., PMID:29593041
Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo., PMID:29367852
Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacy., PMID:28871961
Epidemiological and molecular characteristics of emergent dengue virus in Yunnan Province near the China-Myanmar-Laos border, 2013-2015., PMID:28482813
Increased sensitivity of NS1 ELISA by heat dissociation in acute dengue 4 cases., PMID:28284209
Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies., PMID:27821688
Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies., PMID:27301568
Population genomics of dengue virus serotype 4: insights into genetic structure and evolution., PMID:27169727
Characterization of the 2013 dengue epidemic in Myanmar with dengue virus 1 as the dominant serotype., PMID:27154331
Development of a recombinant, chimeric tetravalent dengue vaccine candidate., PMID:26585500
Comprehensive mapping of functional epitopes on dengue virus glycoprotein E DIII for binding to broadly neutralizing antibodies 4E11 and 4E5A by phage display., PMID:26339794
Comparison of E and NS1 antigens capture ELISA to detect dengue viral antigens from mosquitoes., PMID:26119545
Vector competence of the Aedes aegypti population from Santiago Island, Cape Verde, to different serotypes of dengue virus., PMID:25888847
Computational prediction and analysis of envelop glycoprotein epitopes of DENV-2 and DENV-3 Pakistani isolates: a first step towards Dengue vaccine development., PMID:25775090
Nonstructural protein 1-specific immunoglobulin M and G antibody capture enzyme-linked immunosorbent assays in diagnosis of flaviviral infections in humans., PMID:25502522
False-negative dengue cases in Roraima, Brazil: an approach regarding the high number of negative results by NS1 ag kits., PMID:25229228
Continuous dengue type 1 virus genotype shifts followed by co-circulation, clade shifts and subsequent disappearance in Surabaya, Indonesia, 2008-2013., PMID:25219342
Dengue virus 2 American-Asian genotype identified during the 2006/2007 outbreak in Piauí, Brazil reveals a Caribbean route of introduction and dissemination of dengue virus in Brazil., PMID:25127366
[Selection of heparin-sensitive dengue virus variants in BHK-21 cells]., PMID:24974631
For research use only. Not for human or drug use.
